glp 1 ncbi Metabolic responses and benefits of glucagon‐like peptide‐1 (GLP‐1) receptor ligands The Multifaceted Nature of GLP-1:

National Institute for Health and Care Excellence (2020) Liraglutide for managing overweight and obesity

Interventions Participants consumed one sachet of either i) L-Carnitine-combination (1500 mg given as 2200 mg Carnipure tartrate (Lonza, Switzerland), 2000 mg L-leucine, 3000 mg creatine monohydrate, and 0.01 mg (400 IU) of vitamin-D3), ii) L-Carnitine (1500 mg given as 2200 mg Carnipure tartrate (Lonza, Switzerland)), or iii) appearance- and taste-matched placebo each day, in the morning with breakfast

C.GermeyerA.et al (1998)

Despite their potential to potentiate SDF-1 and thereby exacerbate the vascular complications of type 2 diabetes, DPP-4 inhibitors have emerged as a popular choice for the treatment of the disease because of their ease of use, tolerability and ability to produce predictable and sustained lowering of blood glucose